Pregnancy and breastfeeding : GLP-1 medications are generally not recommended during pregnancy or breastfeeding
This is where your Tirzepatide journey begins
In the SUSTAIN-6 trial of semaglutide for type 2 diabetes, EWDR occurred with significant glucose reductions, particularly in participants who were also receiving insulin or who had more than background retinopathy at baseline (Marso et al, 2016)
Potential Health Problems Linked to Ozempic, Wegovy, and Other Weight Loss Drugs Recent studies and reports highlight that Ozempic, Wegovy, and other GLP-1 receptor agonist drugs are associated with serious health risks, including stomach paralysis, also known as gastroparesis, as well as other gastrointestinal issues
M.GombartZ
Why Choose Troy Watson for Semaglutide GLP-1 Medical Weight Loss in Roseville, CA Why does Semaglutide GLP-1 cause weight loss